Clinically, patients with IgA-producing B cell infiltration tend to have poorer survival in CRC and melanoma, and high level of intratumoral IgA associates with shorter survival in bladder cancer​ [197, 212–215]. This evidence concerns the gene CD79A and urinary bladder carcinoma.